Free tool
FAERS Monitor: Isentress Hd
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022145 or its brand name (Isentress Hd, Raltegravir Potassium). Reports on generic versions are filed under their own applications.
Reports
16,486
Serious
13,706
83% of reports
Hospitalization
5,060
Death reported
1,641
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug interaction1,216
- foetal exposure during pregnancy1,100
- depression1,018
- anxiety965
- pain917
- emotional distress789
- maternal exposure during pregnancy750
- exposure during pregnancy744
- anhedonia708
- virologic failure587
- renal failure558
- chronic kidney disease548
- fatigue530
- diarrhoea527
- off label use486
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 1 |
| 2007 | 17 |
| 2008 | 449 |
| 2009 | 648 |
| 2010 | 739 |
| 2011 | 611 |
| 2012 | 1,020 |
| 2013 | 936 |
| 2014 | 1,051 |
| 2015 | 1,147 |
| 2016 | 1,312 |
| 2017 | 1,044 |
| 2018 | 1,442 |
| 2019 | 1,491 |
| 2020 | 1,204 |
| 2021 | 1,052 |
| 2022 | 891 |
| 2023 | 695 |
| 2024 | 318 |
| 2025 | 256 |
| 2026 | 162 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,037,673 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| virologic failureSignal | 587 | 156.2 | 143.6 | 80,523 |
| anhedoniaSignal | 708 | 35.3 | 32.8 | 22,952 |
| foetal exposure during pregnancySignal | 1,100 | 17.5 | 16.5 | 16,917 |
| exposure during pregnancySignal | 744 | 15.4 | 14.4 | 9,946 |
| maternal exposure during pregnancySignal | 750 | 10.8 | 10.1 | 6,646 |
| drug interactionSignal | 1,216 | 9.8 | 9.3 | 9,655 |
| chronic kidney diseaseSignal | 548 | 9.3 | 8.5 | 4,015 |
| emotional distressSignal | 789 | 8.4 | 7.8 | 5,103 |
| depressionSignal | 1,018 | 5.7 | 5.4 | 3,995 |
| renal failureSignal | 558 | 5.4 | 5.0 | 1,989 |
| anxietySignal | 965 | 4.3 | 4.1 | 2,500 |
| pain | 917 | 1.9 | 1.8 | 405 |
| diarrhoea | 527 | 1.0 | 1.0 | 1 |
| fatigue | 530 | 0.9 | 0.8 | 11 |
| off label use | 486 | 0.7 | 0.6 | 61 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.